The Maybridge portfolio offers a comprehensive range of chemistry products and services tailored to the drug discovery and biotechnology sector. For 45 years, Maybridge has been at the forefront of innovative heterocyclic building block design, fuelled by the desire to access novel molecules of pharmaceutical interest. The Maybridge portfolio is driven by a keen understanding of the needs of the medicinal chemist and is designed to expedite the drug discovery process through: REACTIVE INTERMED...